Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net income (loss)	$ (6,321)	$ (9,630)
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Realized (gains) losses on sale of investments and other assets	(3,164)	1,251
Net deferred policy acquisition costs	4,819	9,054
Amortization of cost of customer relationships acquired	1,192	1,517
Depreciation	1,269	921
Amortization of premiums and discounts on investments	10,422	12,781
Stock-based compensation	1,930	310
Deferred federal income tax benefit	560	59,329
Change in:
Accrued investment income	819	673
Reinsurance recoverable	68	89
Due premiums	2,588	427
Future policy benefit reserves	27,994	33,425
Other policyholders' liabilities	2,309	1,413
Federal income tax receivable	6,580	(45,678)
Commissions payable and other liabilities	1,699	558
Other, net	(1,851)	(1,205)
Net cash provided by operating activities	50,913	65,235
Cash flows from investing activities:
Purchase of fixed maturities, available-for-sale	(210,445)	(109,642)
Sale of fixed maturities, available-for-sale	39,708	1,084
Maturities and calls of fixed maturities, available-for-sale	111,757	51,190
Maturities and calls of fixed maturities, held-to-maturity	0	20,699
Purchase of equity securities	0	(9)
Principal payments on mortgage loans	6	7
Increase in policy loans, net	(1,141)	(5,277)
Sale of other long-term investments and real estate	6,981	14
Sale of property and equipment	15	0
Purchase of property and equipment	(509)	(437)
Maturity of short-term investments	7,940	0
Purchase of short-term investments	(2,456)	0
Net cash used in investing activities	(48,144)	(42,371)
Cash flows from financing activities:
Annuity deposits	4,948	5,222
Annuity withdrawals	(5,685)	(5,397)
Other	(377)	0
Net cash provided by financing activities	(1,114)	(175)
Net increase (decrease) in cash and cash equivalents	1,655	22,689
Cash and cash equivalents at beginning of year	45,492	46,064
Cash and cash equivalents at end of period	$ 47,147	$ 68,753